“SHORRT” drug-resistant Tuberculosis (TB) treatment on cards

Zimbabwe is set to roll out a Shorter, Highly-effective, Oral Regimen for Rifampicin-resistant Tuberculosis (SHORRT therapy) which reduces the length of treatment for Multi-Drug Resistant Tuberculosis (MDR-TB) from nearly two years, to, nine to 12 months and brings a major improvement in treatment outcomes and quality of life of patients. The nearly two-year-treatment regimen used […]

Zimbabwe is set to roll out a Shorter, Highly-effective, Oral Regimen for Rifampicin-resistant Tuberculo...

Source : http://feedproxy.google.com/~r/Appa-sourceTheAfric...